CRVS

#2497
Corvus Pharmaceuticals, Inc. - Common Stock
10.0 5 USD
-0.04%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
10.02
10.50
Jahresspanne
6.39
26.95
Tagesänderung
-4.47%
Monatliche Änderung
-22.21%
6 month change
-33.93%
Jahresänderung
+45.65%
Vorheriger Schlusskurs
10.5 2
Open
10.4 3
Tief
10.0 2
Hoch
10.5 0
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Documents

2024

Quarterly report, Q3 FY2024

Corvus Pharmaceuticals, Inc. quarterly report, Q3 FY2024
10-Q

Current report, Q3 FY2024

Corvus Pharmaceuticals, Inc. current report, Q3 FY2024
8-K

Quarterly report, Q2 FY2024

Corvus Pharmaceuticals, Inc. quarterly report, Q2 FY2024
10-Q

Current report, Q2 FY2024

Corvus Pharmaceuticals, Inc. current report, Q2 FY2024
8-K

Current report, 06 May 2024

Corvus Pharmaceuticals, Inc. current report, 06 May 2024
8-K

Current report, 01 May 2024

Corvus Pharmaceuticals, Inc. current report, 01 May 2024
8-K

Current report, 01 May 2024

Corvus Pharmaceuticals, Inc. current report, 01 May 2024
8-K

Quarterly report, Q1 FY2024

Corvus Pharmaceuticals, Inc. quarterly report, Q1 FY2024
10-Q

Current report, 19 Mar 2024

Corvus Pharmaceuticals, Inc. current report, 19 March 2024
8-K

Current report, 23 Jan 2024

Corvus Pharmaceuticals, Inc. current report, 23 January 2024
8-K

Nachrichten